Ranking · Unmet Need
Trial Gap Index
Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.
Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics
| Rank | Δ | Cancer | Trial Gap Index (percentile points) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Colon Neoplasm | +52 | 100 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600766 |
| 2 | = | Cutaneous Melanoma | +24 | 96 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600767 |
| 2 | = | Malignant Bladder Neoplasm | +24 | 96 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600769 |
| 2 | = | Malignant Laryngeal Neoplasm | +24 | 96 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600768 |
| 5 | = | Malignant Esophageal Neoplasm | +16 | 84 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600770 |
| 5 | = | Malignant Salivary Gland Neoplasm | +16 | 84 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600771 |
| 7 | = | Malignant Pancreatic Neoplasm | +12 | 76 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600772 |
| 7 | = | Malignant Prostate Neoplasm | +12 | 76 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600773 |
| 9 | = | Malignant Kidney Neoplasm | +8 | 68 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600775 |
| 9 | = | Malignant Mesothelioma | +8 | 68 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600774 |
| 9 | = | Malignant Testicular Neoplasm | +8 | 68 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600776 |
| 12 | = | Malignant Liver Neoplasm | +4 | 56 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600777 |
| 13 | = | Malignant Lung Neoplasm | 0 | 52 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600778 |
| 13 | = | Malignant Penile Neoplasm | 0 | 52 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600780 |
| 13 | = | Malignant Thyroid Gland Neoplasm | 0 | 52 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600779 |
| 16 | = | Leukemia | -8 | 40 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600781 |
| 16 | = | Malignant Gastric Neoplasm | -8 | 40 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600782 |
| 16 | = | Malignant Hypopharyngeal Neoplasm | -8 | 40 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600783 |
| 16 | = | Malignant Rectal Neoplasm | -8 | 40 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600784 |
| 20 | = | Hodgkin Lymphoma | -12 | 24 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600785 |
| 20 | = | Malignant Anal Neoplasm | -12 | 24 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600787 |
| 20 | = | Malignant Central Nervous System Neoplasm | -12 | 24 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600786 |
| 23 | = | Multiple Myeloma | -16 | 12 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600788 |
| 24 | = | Malignant Nasopharyngeal Neoplasm | -24 | 8 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600790 |
| 24 | = | Non-Hodgkin Lymphoma | -24 | 8 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600789 |
| 26 | = | Malignant Breast Neoplasm | -80 | 0 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2600791 |
Data updated 16 hours agoSource updated unknown26 eligible entities · inputs hash 17859bf5c8ad1c08a7c63ac4